The Massachusetts Society of Clinical Oncologists (MSCO) and the Association for Clinical Oncology (ASCO) are pleased to submit a letter of support of H. 982, a bill that would protect Massachusetts patients from non-medical switching of medications. MSCO and ASCO are encouraged by the steps that H. 982 takes toward improving continuity of care and preventing non-medical switching in Massachusetts. We urged the committee to vote for passage on this measure.